Alzheimer’s care, quality of life improve with innovative Immersion Room
By
Jessica R. Towhey
Aug 01, 2024
A creative new room at a Long Island, NY, nursing home may serve as a model for improving the quality of life and care through non-pharmacological interventions for residents diagnosed with Alzheimer’s...
Taking it to the streets: Reimagining dementia
By
Mary Fridley
Charles de Vilmorin
Oct 30, 2023
When Reimagining Dementia: A Creative Coalition for Justice launched “Taking It to the Streets,” a global campaign that took place during the week of Sept. 18 to 24, 2023, one of the first people to...
Two new studies identify potential warning signs of cognitive decline in older adults
By
John Roszkowski
Oct 13, 2023
Older adults who show subtle decline on standard memory and cognitive tests may be at increased risk for developing mild cognitive impairment, a precursor to dementia, according to the results of a new...
Medicare’s plan to cover Alzheimer’s drugs hinges on patient data registries
By
Alicia Lasek
Jun 02, 2023
Medicare Part B will cover Alzheimer’s drugs with traditional FDA approval, CMS announced Thursday. Prescribing clinicians must participate in a patient data registry.
BREAKING: FDA approves new experimental drug to treat early Alzheimer’s
By
Alicia Lasek
Jan 06, 2023
The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.
Our simple, revolutionary tool to understanding those living with dementia
By
Angie Frantz
Aug 01, 2022
I recently had the honor of attending the Alzheimer’s Disease International (ADI) 2022 Global Conference in London, England, where I presented a memory care initiative that we’ve been rolling out across...
VA will not add Alzheimer’s drug Aduhelm to its formulary
By
Alicia Lasek
Aug 12, 2021
The Department of Veterans Affairs has chosen not to include aducanumab (Aduhelm) in its national list of covered drugs, citing risk of adverse events and lack of evidence of positive impact on cognition,...
Slow buy-in: Only 3% of neurologists have written Aduhelm prescriptions so far
By
Alicia Lasek
Jul 15, 2021
Neurologists are very aware of Biogen’s newly approved Alzheimer’s drug, but few have prescribed it so far, a real-time study of the brand’s market launch has found.
Video gold: Despite pandemic obstacles, husband keeps love story alive for wife with Alzheimer’s
By
Danielle Brown
Feb 17, 2021
In a love story that rivals “The Notebook,” a Michigan man has proven that no obstacle is too big to stop him from seeing his wife daily in a push to help her remember their love for one another.
‘Awakenings’ in advanced dementia patients inspire search for a cause
By
Alicia Lasek
Aug 07, 2019
Scientists have begun a search for the cause of a phenomena where people with late-stage Alzheimer’s disease are very lucid near the end of life.